Andrew Krystal, MD, and Wayne Drevets, MD, share their thoughts on the recent seltorexant data presented at the 2024 ASCP Annual Meeting.
Wayne Drevets, MD
Advertisement
Dr Drevets is vice president and neuropsychiatry disease area stronghold leader at Johnson & Johnson.
Articles by Wayne Drevets, MD
Advertisement
Latest Updated Articles
Seltorexant, Major Depressive Disorder, and Insomnia: Thoughts on the New DataPublished: June 6th 2024 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases
2
Preliminary Report on Dangers of AI Chatbots
3
The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law
4
Suicide: Can Emergency Departments Assist in its Prevention?
5
